Management of type 2 diabetes: A handbook for general practice

Complications

Diabetes-related foot care

Complictions | Diabetes-related foot care


Recommendation 

Grade 

References 

Recommended as of:

Assess all people with diabetes and stratify their risk by enquiring about previous foot ulceration and amputation, visually inspecting the feet for structural abnormalities and ulceration, assessing for neuropathy using either the Neuropathy Disability Score or a 10-g monofilament, and palpating foot.

C

1,2

14/11/2024

In people stratified as having low-risk feet (where no risk factors or previous foot complications have been identified), foot examination should occur annually. 

Consensus 

1 

14/11/2024

Repeat screening once every 6–12 months for those classified as International Working Group on the Diabetic Foot (IWGDF) risk 1 , once every 3–6 months for those classified as IWGDF risk 2  and once every 1–3 months for those classified as IWGDF risk 3 . 

Strong; low 

14/11/2024

Pressure reduction, otherwise referred to as ‘redistribution of pressure’ or ‘off-loading’, is required to optimise the healing of plantar foot ulcers.  

14/11/2024

People with diabetes-related foot ulceration are best managed by a multidisciplinary foot care team. 

1 

14/11/2024

Dressings should be selected principally on the basis of exudate control, comfort and cost. 

Strong; low 

14/11/2024

Non-viable tissue should be debrided. 

A, Level 1 

14/11/2024

Diabetes foot care prevention includes examining and inspecting the feet, providing individualised education about self-management for foot care and instructions on the need for early assessment for any concerning signs of risk such as injury or deformity. 

People assessed as having intermediate-risk or high-risk feet should be offered a foot protection program. A foot protection program that includes prevention, foot care education, multidisciplinary care4 and close monitoring and treatment of foot ulcers can substantially reduce amputation rates. This includes podiatry review and appropriate footwear. 

Foot ulceration and limb amputation are among the major drivers of disability and healthcare costs in people with diabetes. Foot ulceration as a lifetime risk in diabetes is estimated to be 19–34%.5 In Australia, 12,500 people have had a diabetes-related amputation and 12 people each day may undergo a diabetes-related amputation.6

For information about the Foot Forward program to prevent amputation, contact Diabetes Australia

Patient education and support 

Foot care education should be provided to all people with diabetes to assist with the prevention of foot complications. 

Patient education and support regarding foot care should include: 

  • emphasising the importance of appropriate footwear and foot care (improper footwear and tinea infection are associated with increased problems) 
  • establishing a regular self-monitoring schedule (including visual checks) 
  • developing an action plan to respond to early problems (eg skin breakdown). 

Assessing the risk of foot complications 

A comprehensive Diabetes and feet toolkit, published by the National Diabetes Services Scheme, is available to guide the careful assessment, prevention and management of diabetes-related foot complications.7 

A careful foot assessment should be performed to stratify the risk of developing foot complications. Stratification is dependent on four risk factors:

  • peripheral arterial disease (PAD), which can be assessed by dorsalis pedis and tibialis anterior pulses or hand-held Doppler; if problems are suspected, consider ankle–brachial pressure index (ABI) testing, toe–brachial index (TBI) testing or absolute toe pressure, with an understanding of the clinical limitations of each method 
  • peripheral neuropathy, which can be assessed using the neuropathy disability score or a 10-g monofilament 
  • deformities 
  • previous amputation or ulceration. 

The following factors might also increase the risk of foot complications:

  • visual impairment 
  • kidney disease 
  • suboptimal glucose management 
  • ill-fitting footwear 
  • socioeconomic disadvantage. 

To determine foot screening requirements, refer to the International Working Group on the Diabetic Foot (IWGDF) risk stratification system in the 2021 Australian guidelines for diabetes-related foot disease.2 (The stratification system refers to the loss of peripheral sensation [LOPS] and peripheral artery disease [PAD].) People at intermediate and high risk should be assessed by a diabetic high-risk foot service. The intensity of monitoring and review increases according to the level of risk. 

For practice-based tools to assess circulation and foot deformity, refer to ‘Complications: Diabetes-related neuropathy’. 

Indications for immediate referral to a multidisciplinary foot care clinic include active foot disease, such as: 

  • foot ulcer, with or without local Infection 
  • suspected Charcot neuroarthropathy (eg unilateral, red, hot, swollen, possibly aching foot). 

Any patients presenting with acute limb ischaemia should be referred immediately to an emergency department. 

Patients with chronic limb-threatening ischaemia require urgent referral to a vascular specialist/surgeon. Look for the 5P’s: acute onset of progressive pain in the affected limb (pain), pulselessness, pallor, paraesthesia and paralysis.7 

Foot ulceration 

A foot ulcer is a serious condition and needs to be managed immediately. 

Assessment 

Several wound classifications have been developed to provide objective assessment of the severity of foot ulcers. 

  • The IWGDF guidelines recommend using IWGDF/Infectious Diseases Society of America (IDSA) classification criteria to assess infection severity.9 

  • The Wound, Ischaemia, foot Infection (WIfI) system is recommended for use in people with PAD to stratify amputation risk and revascularisation benefit.9

  • The Site, Ischaemia, Neuropathy, Bacterial infection, Area, Depth (SINBAD) system is recommended for communication between health professionals (Table 1).10 

If arterial insufficiency is suspected, assessment and management of the peripheral vasculature is mandatory before debridement. 

Referral to a vascular surgeon, high-risk foot clinic and/or multidisciplinary team is suggested in this situation. 

Table 1. The SINBAD wound classification system10 

Clinical domain 

Condition 

Score* 

Site 

Forefoot 

Mid-foot/hind foot 

Ischaemia 

Pedal blood flow intact (at least one pulse palpable) 

Clinical evidence of reduced pedal blood flow 

Neuropathy 

Protective sensation intact 

Protective sensation lost 

Bacterial infection 

None present 

Present 

Area 

Ulcer <1 cm2 

Ulcer ≥1 cm2 

Depth 

Ulcer confined to the skin and subcutaneous tissue 

Ulcer reaching the muscle, tendon or deeper 

*The highest total possible score is 6. Scores >3 are considered elevated risk.10 


Wound management 

A patient’s ability to understand and undertake management should always be a factor in choosing a treatment and in counselling the patient regarding the treatment plan. 

The general principles of wound care include the provision of a physiologically moist wound environment and off-loading the ulcer. Off-loading of the wound can be achieved with the use of a total contact cast or other irremovable devices.12 

Debridement 

Local sharp debridement of non-ischaemic wounds improves healing and should be performed by a suitably qualified health professional. 

The priority of debriding wound tissue is to prepare the surface and edges of a wound to facilitate healing. Debridement also reduces pressure on the wound, allows for full inspection of tissue underneath the debrided tissue and helps drain secretions or pus.13

Wound dressings 

Dressings should be selected principally on the basis of exudate control, comfort and cost, and therefore be tailored to the specific characteristics of the wound. 

  • In non-ischaemic ulcers, create a moist wound environment. 
  • Appropriate management of wound exudate levels should be a guiding principle in dressing selection and the frequency of dressing change. 
  • In ischaemic ulcers, maintain a dry wound environment using a dry, non-adherent dressing until someone with experience in PAD has reviewed the wound. 

A full list of considerations for dressing choice can be found on page 50 of the Diabetes and feet toolkit.6 

Off-loading devices 

Ongoing weight bearing on an insensate foot causes continued trauma and results in poor wound healing. 

Pressure on the wound should be off-loaded, using padding or other off-loading devices, such as total contact casts and removable prefabricated devices (eg controlled ankle movement walkers, half-shoes, therapeutic shoes). 

Ulcers are often caused by patients’ footwear; if this is the case, advise the patient not to continue wearing the same shoes. 

Guidelines on footwear for people with diabetes can be found in the Diabetes and feet toolkit and in an article by van Netten et al.14 

Infection 

The need for antibiotics should be determined on clinical grounds and appropriate choices based on what is appropriate for the patient. 

It is appropriate for cultures to be collected for identification of microbiological organisms and antibiotic sensitivities. The most appropriate tissue samples for microbiological evaluation are either deep tissue swabs after debridement or tissue/bone biopsies. 

There is no need to culture clinically uninfected ulcers, because colonising organisms will always be detected. 

Infected ulcers should be treated with antimicrobial therapy according to published antibiotic guidelines

The duration of therapy may need to be for extended periods. 

It is not recommended to use topical antibiotic therapy to treat mild diabetes wound infections.6 

  1. National Health and Medical Research Council (NHMRC). National evidence-based guideline: Prevention, identification and management of foot complications in diabetes. NHMRC, 2011.
  2. Diabetes Feet Australia. 2021 Evidence-based Australian guidelines for diabetes-related foot disease. Diabetes Feet Australia, 2021 [Accessed 4 September 2024].
  3. Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2018;42(Suppl 1):S1–326.
  4. Musuuza J, Sutherland BL, Kurter S, Balasubramanian P, Bartels CM, Brennan MB. A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers. J Vasc Surg 2020;71(4):1433–46.e3. doi: 10.1016/j.jvs.2019.08.244.
  5. Reardon R, Simring D, Kim B, Mortensen J, Williams D, Leslie A. The diabetic foot ulcer. Aust J Gen Pract 2020;49(5):250–55. doi: 10.31128/AJGP-11-19-5161.
  6. Van Netten JJ, Lazzarini PA, Fitridge R, Kinnear E, et al. Australian diabetes-related foot disease strategy 2018–2022: The first step towards ending avoidable amputations within a generation. Diabetes Feet Australia, 2017 [Accessed 4 September 2024].
  7. Diabetes Australia. Diabetes and feet: A practical toolkit for health professionals using the Australian diabetes-related foot disease guidelines. Diabetes Australia, 2022 [Accessed 4 September 2024].
  8. Obara H, Matsubara K, Kitagawa Y. Acute limb ischemia. Ann Vasc Dis 2018;11(4):443–48. doi: 10.3400/avd.ra.18-00074.
  9. Schaper NC, van Netten JJ, Apelqvist J, et al. IWGDF guidelines on the prevention and management of diabetic foot disease. International Working Group on the Diabetic Foot, 2023 [Accessed 17 September 2024].
  10. Ince P, Abbas ZG, Lutale JK, et al. Use of the SINBAD classification system and score in comparing outcome of foot ulcer management on three continents. Diabetes Care 2008;31(5):964–67. doi: 10.2337/dc07-2367.
  11. Ha Van G, Schuldiner S, Sultan A, et al. Use of the SINBAD score as a predicting tool for major adverse foot events in patients with diabetic foot ulcer: A French multicentre study. Diabetes Metab Res Rev 2023;39(8):e3705. doi: 10.1002/dmrr.3705.
  12. Bus SA, Armstrong DG, Gooday C, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev 2020;36(Suppl 1):e3274. doi: 10.1002/dmrr.3274.
  13. Wounds International. International best practice guidelines: Wound management in diabetic foot ulcers. Wounds International, 2013 [Accessed 4 September 2024].
  14. van Netten JJ, Lazzarini PA, Armstrong DG, et al. Diabetic Foot Australia guideline on footwear for people with diabetes. J Foot Ankle Res 2018;11(2):2. doi: 10.1186/s13047-017-0244-z.
This event attracts CPD points and can be self recorded

Did you know you can now log your CPD with a click of a button?

Create Quick log


 

Advertising